---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-092690"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2026-08-21T21:17:59+00:00"
generated_at: "2026-08-21T21:20:04.093130+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Adial receives Nasdaq delisting notice for equity shortfall

## Summary
- On Aug 18, 2026, Nasdaq said stockholders' equity fell below $2.5M minimum for continued listing.
- Company also fails alternative $35M market value or $500K net income standards.
- Must submit compliance plan by Oct 2, 2026; intends to convert Series A preferred stock at 2026 annual meeting.
- If accepted, Nasdaq may grant up to 180-day extension; delisting stay via hearing possible.

## SEC filing metadata
- accession: 0001213900-26-092690
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2026-08-21T21:17:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390026092690/0001213900-26-092690-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390026092690/ea0302970-8k_adial.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-092690
- JSON: https://secwatch.observer/filing/0001213900-26-092690.json
- Plain text: https://secwatch.observer/filing/0001213900-26-092690.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.